NCT05263050 2025-12-03Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine TumorsFox Chase Cancer CenterPhase 2 Recruiting111 enrolled
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled
NCT04889742 2023-12-26HETEREROCharite University, Berlin, GermanyPhase 2 Not yet recruiting110 enrolled